Dermakare Pharmaceuticals Private Limited

Dermakare Pharmaceuticals Private Limited - pharma in Lucknow, Uttar Pradesh, India. FY 2026 financials & compliance.
CIN U74900UP2011PTC043538 Incorporated 12 February 2011 ROC Kanpur HQ Lucknow, Uttar Pradesh, India
Active Private Limited Company pharma MSME · Small
Revenue · FY 2024
₹12.35 Cr
▲ 11% YoY
Net profit · FY 2024
₹12.89 Lakh
Net margin 1%
EBITDA · FY 2024
₹1.21 Cr
EBITDA margin 9.8%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹61.81 Lakh
Issued & subscribed
Open charges
₹4.43 Cr
Satisfied ₹4.11 Cr
Company age
15 yrs
Est. 2011
Employees · EPFO
74
Provident fund records

About Dermakare Pharmaceuticals Private Limited

Data last updated:

Dermakare Pharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 February 2011 and has been in existence for over 15 years.

The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U74900UP2011PTC043538. Its GSTIN is 09AADCD7226K1ZF (Uttar Pradesh). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹61.81 Lakh. It is led by directors including Roop Chand Rastogi and Archana.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at F – 390 Transport Nagar Kanpur Road, Lucknow, Uttar Pradesh, India – 226012.

As per the financials filed for FY 2024, the company reported a revenue of ₹12.35 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹12.89 Lakh (net margin 1%) and EBITDA of ₹1.21 Cr (EBITDA margin 9.8%). Revenue has declined at a compounded annual rate (CAGR) of 1% over three years and 7% over five years.

The company has about 74 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Dermakare Pharmaceuticals. As per MCA filings, the company has open charges of ₹4.43 Cr and satisfied charges of ₹4.11 Cr on record. Court records list 1 case involving the company, including 1 filed against it; 1 case is pending. The company has 2 deals on record (2 funding rounds), with disclosed funding of ₹48.5 Lakh; the latest was in August 2014. Its 3 peer companies in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading) are compared by revenue, 2 larger and 1 smaller; the largest is Scout Lifescience Private Limited with revenue of ₹12.41 Cr.

Dermakare Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-50-0021485). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website dermakarepharma.in.

Company details

CIN U74900UP2011PTC043538
Registration Number 043538
Incorporation Date 12 February 2011
ROC Kanpur
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-UP-50-0021485

Recognitions & Rankings of Dermakare Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Small (2023-24)
Udyam number
UDYAM-UP-50-0021485

Contact details

Dermakare Pharmaceuticals Private Limited's registered office is in Lucknow, Uttar Pradesh. Its website is dermakarepharma.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    F – 390 Transport Nagar Kanpur Road, Lucknow, Uttar Pradesh, India – 226012
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Dermakare Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Dermakare Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Dermakare Pharmaceuticals operates one associated brand: Dermakare Pharmaceuticals. Each brand links to its own profile.

BrandDescriptionWebsite
Manufactures and distributes a wide range of dermatological pharmaceutical products.dermakarepharma.in

Business activity

The main business activity of Dermakare Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Dermakare Pharmaceuticals Private Limited, buy the company report.

Financials of Dermakare Pharmaceuticals Private Limited

FY 2024 filings available

Dermakare Pharmaceuticals Private Limited reported revenue of ₹12.35 Cr (up 11% YoY) for FY 2024.

Revenue · FY 2024
₹12.35 Cr ▲ 11%
Net profit · FY 2024
₹12.89 Lakh margin 1%
EBITDA · FY 2024
₹1.21 Cr margin 9.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 11%
3 years · compounded
▲ 1%
5 years · compounded
▼ 7%
EBITDA CAGR growth
1 year
▲ 11%
3 years · compounded
▲ 10%
5 years · compounded
▼ 5%

Revenue rose 11% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 7%. EBITDA rose 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.21 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹12.89 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin9.8%
Net Profit Margin1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Dermakare Pharmaceuticals Private Limited, buy the company report.

Board of directors of Dermakare Pharmaceuticals Private Limited

Dermakare Pharmaceuticals has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Roop Chand RastogiDirector12 Feb 201115 Years 9 MonthsCurrent
ArchanaDirector01 May 201313 Years 6 MonthsCurrent
Veshali PorwalDirector01 May 201313 Years 6 MonthsCurrent
Madhuri MishraDirector15 Jul 201313 Years 4 MonthsCurrent

Peer comparison

Dermakare Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Scout Lifescience Private Limited₹12.41 Cr (FY 2025)49.0%Naraingarh, Haryana, India
Repens Healthcare India Private Limited₹12.35 Cr (FY 2025)19.0%Bhayander, Maharashtra, India
Dermakare Pharmaceuticals Private Limitedthis company₹12.35 Cr (FY 2024)₹12.89 Lakh1%11.0%74Lucknow, Uttar Pradesh, India
Mtor Life Sciences Private Limited₹12.26 Cr (FY 2025)100.0%New Delhi, Delhi, India

To see the full peer comparison of Dermakare Pharmaceuticals Private Limited, buy the company report.

Auditor

Dermakare Pharmaceuticals Private Limited is audited by OM RASTOGI AND COMPANY for the financial year 2023.

Auditor firmFinancial yearFirm registration number
OM RASTOGI AND COMPANYFY 2023002604C

Shareholding

The shareholding of Dermakare Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Dermakare Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹4.43 Cr
Satisfied charges
₹4.11 Cr
Breakdown by lending institutions
Others₹4.08 Cr
Axis Bank Limited₹0.35 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
28 Jan 2022100549646Others₹4.08 CrOpen
06 Aug 2021100473842Axis Bank Limited₹35.37 LakhOpen
29 Jun 2020100368401Others₹54 LakhSatisfied
29 Nov 201410535427Others₹3.5 CrSatisfied
29 Jan 201410480478Canara Bank₹7 LakhSatisfied

To see the full charge records of Dermakare Pharmaceuticals Private Limited, buy the company report.

Total charge records: 5 View all charges

Deals & funding

Dermakare Pharmaceuticals Private Limited has 2 deals on record (2 funding rounds), with disclosed funding of ₹48.5 Lakh; the latest was in August 2014.

Total deals
2
Funding rounds
2
Disclosed funding
₹48.5 Lakh

Deals on record (2 of 2)

WhenDealAmountParties
Aug 2014Funding round₹36.4 LakhInvestors: 3 individuals
Jul 2012Funding round₹12.1 LakhInvestors: 3 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Dermakare Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Dermakare Pharmaceuticals Private Limited has a workforce of 74 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
74
Active EPFO establishments
1
Employee growth
13.8%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2774
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Dermakare Pharmaceuticals Private Limited, buy the company report.

GST

Dermakare Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
09AADCD7226K1ZFUttar PradeshActive01 Jul 2017

To see the full GST registrations and return filing status of Dermakare Pharmaceuticals Private Limited, buy the company report.

Recent activity

Dermakare Pharmaceuticals Private Limited has 12 board changes on record since 2011: 8 appointments and 4 cessations. The latest: Madhuri Mishra was appointed as Director on 15 Jul 2013.

AGM
Dermakare Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Dermakare Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur.
Charges
A charge with Others of Rs. 4.08 Cr registered on 28 Jan 2022 with Charge ID 100549646 was modified on 10 May 2022.
Charges
A charge registered on 29 Jun 2020 via Charge ID 100368401 with Others was fully satisfied on 10 Mar 2022.
Charges
A charge registered on 29 Nov 2014 via Charge ID 10535427 with Others was fully satisfied on 10 Mar 2022.
Charges
A charge with Others amounted to Rs. 4.08 Cr with Charge ID 100549646 was registered on 28 Jan 2022.
Charges
A charge with Axis Bank Limited amounted to Rs. 0.35 Cr with Charge ID 100473842 was registered on 06 Aug 2021.
Charges
A charge with Others amounted to Rs. 0.54 Cr with Charge ID 100368401 was registered on 29 Jun 2020.
Charges
A charge with Others of Rs. 3.50 Cr registered on 29 Nov 2014 with Charge ID 10535427 was modified on 28 Jan 2020.
Charges
A charge registered on 29 Jan 2014 via Charge ID 10480478 with Canara Bank was fully satisfied on 07 Sep 2015.
Charges
A charge with Others amounted to Rs. 3.50 Cr with Charge ID 10535427 was registered on 29 Nov 2014.
Charges
A charge with Canara Bank amounted to Rs. 0.07 Cr with Charge ID 10480478 was registered on 29 Jan 2014.

13 earlier events are in the company report.

Frequently asked questions

Dermakare Pharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 February 2011 (15+ years old) and is registered under CIN U74900UP2011PTC043538.

Dermakare Pharmaceuticals has 4 current directors:

The latest financial statements of Dermakare Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Dermakare Pharmaceuticals is 09AADCD7226K1ZF, registered in Uttar Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Dermakare Pharmaceuticals is U74900UP2011PTC043538. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Dermakare Pharmaceuticals has 1 court case on record: 1 filed against it. 1 is pending.

Dermakare Pharmaceuticals was incorporated on 12 February 2011, making it 15+ years old. It is registered with the Registrar of Companies, Kanpur.

Dermakare Pharmaceuticals has 2 deals on record (2 funding rounds), with disclosed funding of ₹48.5 Lakh; the latest was in August 2014.

The peers of Dermakare Pharmaceuticals by revenue are Scout Lifescience Private Limited, Repens Healthcare India Private Limited, Mtor Life Sciences Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).

Madhuri Mishra was appointed as Director on 15 Jul 2013. Sumit Porwal ceased to be Director on 15 Jul 2013. Archana was appointed as Director on 01 May 2013. Dermakare Pharmaceuticals has 12 board changes on record in total.

Yes, Dermakare Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-UP-50-0021485).